155 related articles for article (PubMed ID: 36224342)
1. Intralesional TLR4 agonist treatment strengthens the organ defense against colonizing cancer cells in the brain.
Blazquez R; Chuang HN; Wenske B; Trigueros L; Wlochowitz D; Liguori R; Ferrazzi F; Regen T; Proescholdt MA; Rohde V; Riemenschneider MJ; Stadelmann C; Bleckmann A; Beißbarth T; van Rossum D; Hanisch UK; Pukrop T
Oncogene; 2022 Nov; 41(46):5008-5019. PubMed ID: 36224342
[TBL] [Abstract][Full Text] [Related]
2. The IRAK4 scaffold integrates TLR4-driven TRIF and MYD88 signaling pathways.
Pereira M; Durso DF; Bryant CE; Kurt-Jones EA; Silverman N; Golenbock DT; Gazzinelli RT
Cell Rep; 2022 Aug; 40(7):111225. PubMed ID: 35977521
[TBL] [Abstract][Full Text] [Related]
3. Signaling of apoptosis through TLRs critically involves toll/IL-1 receptor domain-containing adapter inducing IFN-beta, but not MyD88, in bacteria-infected murine macrophages.
Ruckdeschel K; Pfaffinger G; Haase R; Sing A; Weighardt H; Häcker G; Holzmann B; Heesemann J
J Immunol; 2004 Sep; 173(5):3320-8. PubMed ID: 15322195
[TBL] [Abstract][Full Text] [Related]
4. Endotoxin tolerance dysregulates MyD88- and Toll/IL-1R domain-containing adapter inducing IFN-beta-dependent pathways and increases expression of negative regulators of TLR signaling.
Piao W; Song C; Chen H; Diaz MA; Wahl LM; Fitzgerald KA; Li L; Medvedev AE
J Leukoc Biol; 2009 Oct; 86(4):863-75. PubMed ID: 19656901
[TBL] [Abstract][Full Text] [Related]
5. TLR4/MyD88 signaling determines the metastatic potential of breast cancer cells.
Wu K; Zhang H; Fu Y; Zhu Y; Kong L; Chen L; Zhao F; Yu L; Chen X
Mol Med Rep; 2018 Sep; 18(3):3411-3420. PubMed ID: 30066873
[TBL] [Abstract][Full Text] [Related]
6. Recipient Toll-like receptors contribute to chronic graft dysfunction by both MyD88- and TRIF-dependent signaling.
Wang S; Schmaderer C; Kiss E; Schmidt C; Bonrouhi M; Porubsky S; Gretz N; Schaefer L; Kirschning CJ; Popovic ZV; Gröne HJ
Dis Model Mech; 2010; 3(1-2):92-103. PubMed ID: 20038715
[TBL] [Abstract][Full Text] [Related]
7. Dual regulation of osteopontin production by TLR stimulation in dendritic cells.
Salvi V; Scutera S; Rossi S; Zucca M; Alessandria M; Greco D; Bosisio D; Sozzani S; Musso T
J Leukoc Biol; 2013 Jul; 94(1):147-58. PubMed ID: 23610145
[TBL] [Abstract][Full Text] [Related]
8. Biologically active 1,25-dihydroxyvitamin D3 protects against experimental sepsis by negatively regulating the Toll-like receptor 4/myeloid differentiation primary response gene 88/Toll-IL-1 resistance-domain-containing adapter-inducing interferon-β signaling pathway.
Zheng G; Wen N; Pan M; Huang Y; Li Z
Int J Mol Med; 2019 Sep; 44(3):1151-1160. PubMed ID: 31524226
[TBL] [Abstract][Full Text] [Related]
9. Melatonin attenuates the TLR4-mediated inflammatory response through MyD88- and TRIF-dependent signaling pathways in an in vivo model of ovarian cancer.
Chuffa LG; Fioruci-Fontanelli BA; Mendes LO; Ferreira Seiva FR; Martinez M; Fávaro WJ; Domeniconi RF; Pinheiro PF; Delazari Dos Santos L; Martinez FE
BMC Cancer; 2015 Feb; 15():34. PubMed ID: 25655081
[TBL] [Abstract][Full Text] [Related]
10. Dominant role of the MyD88-dependent signaling pathway in mediating early endotoxin-induced murine ileus.
Buchholz BM; Billiar TR; Bauer AJ
Am J Physiol Gastrointest Liver Physiol; 2010 Aug; 299(2):G531-8. PubMed ID: 20508155
[TBL] [Abstract][Full Text] [Related]
11. Melatonin modulates TLR4-mediated inflammatory genes through MyD88- and TRIF-dependent signaling pathways in lipopolysaccharide-stimulated RAW264.7 cells.
Xia MZ; Liang YL; Wang H; Chen X; Huang YY; Zhang ZH; Chen YH; Zhang C; Zhao M; Xu DX; Song LH
J Pineal Res; 2012 Nov; 53(4):325-34. PubMed ID: 22537289
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor 4 prompts human breast cancer cells invasiveness via lipopolysaccharide stimulation and is overexpressed in patients with lymph node metastasis.
Yang H; Wang B; Wang T; Xu L; He C; Wen H; Yan J; Su H; Zhu X
PLoS One; 2014; 9(10):e109980. PubMed ID: 25299052
[TBL] [Abstract][Full Text] [Related]
13. TLR signaling controls lethal encephalitis in WNV-infected brain.
Sabouri AH; Marcondes MC; Flynn C; Berger M; Xiao N; Fox HS; Sarvetnick NE
Brain Res; 2014 Jul; 1574():84-95. PubMed ID: 24928618
[TBL] [Abstract][Full Text] [Related]
14. TLR4 signaling via MyD88 and TRIF differentially shape the CD4+ T cell response to Porphyromonas gingivalis hemagglutinin B.
Gaddis DE; Michalek SM; Katz J
J Immunol; 2011 May; 186(10):5772-83. PubMed ID: 21498664
[TBL] [Abstract][Full Text] [Related]
15. The TLR4-TRIF pathway can protect against the development of experimental allergic asthma.
Shalaby KH; Al Heialy S; Tsuchiya K; Farahnak S; McGovern TK; Risse PA; Suh WK; Qureshi ST; Martin JG
Immunology; 2017 Sep; 152(1):138-149. PubMed ID: 28502093
[TBL] [Abstract][Full Text] [Related]
16. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
[TBL] [Abstract][Full Text] [Related]
17. CD300a and CD300f differentially regulate the MyD88 and TRIF-mediated TLR signalling pathways through activation of SHP-1 and/or SHP-2 in human monocytic cell lines.
Kim EJ; Lee SM; Suk K; Lee WH
Immunology; 2012 Mar; 135(3):226-35. PubMed ID: 22043923
[TBL] [Abstract][Full Text] [Related]
18. A presumed antagonistic LPS identifies distinct functional organization of TLR4 in mouse microglia.
Döring C; Regen T; Gertig U; van Rossum D; Winkler A; Saiepour N; Brück W; Hanisch UK; Janova H
Glia; 2017 Jul; 65(7):1176-1185. PubMed ID: 28471051
[TBL] [Abstract][Full Text] [Related]
19. The Asp299Gly polymorphism alters TLR4 signaling by interfering with recruitment of MyD88 and TRIF.
Figueroa L; Xiong Y; Song C; Piao W; Vogel SN; Medvedev AE
J Immunol; 2012 May; 188(9):4506-15. PubMed ID: 22474023
[TBL] [Abstract][Full Text] [Related]
20. Regulator of calcineurin 1 differentially regulates TLR-dependent MyD88 and TRIF signaling pathways.
Pang Z; Junkins RD; Raudonis R; MacNeil AJ; McCormick C; Cheng Z; Lin TJ
PLoS One; 2018; 13(5):e0197491. PubMed ID: 29799862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
